摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-2,3-dibromo-2,3,5-trideoxy-β-D-erythro-L-manno-non-2-ulopyranosonate | 108999-04-8

中文名称
——
中文别名
——
英文名称
methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-2,3-dibromo-2,3,5-trideoxy-β-D-erythro-L-manno-non-2-ulopyranosonate
英文别名
methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-2,3-dibromo-2,3,5-trideoxy-β-D-erythro-L-manno-2-nonulopyranosonate;methyl (2S,3R,4R,5S,6R)-5-acetamido-4-acetyloxy-2,3-dibromo-6-[(1S,2R)-1,2,3-triacetyloxypropyl]oxane-2-carboxylate
methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-2,3-dibromo-2,3,5-trideoxy-β-D-erythro-L-manno-non-2-ulopyranosonate化学式
CAS
108999-04-8
化学式
C20H27Br2NO12
mdl
——
分子量
633.242
InChiKey
DSCLWCGSKWCYFK-CIVJTVJESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.28
  • 重原子数:
    35.0
  • 可旋转键数:
    9.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.7
  • 拓扑面积:
    169.83
  • 氢给体数:
    1.0
  • 氢受体数:
    12.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3
    • 4

反应信息

  • 作为反应物:
    描述:
    methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-2,3-dibromo-2,3,5-trideoxy-β-D-erythro-L-manno-non-2-ulopyranosonate 、 sodium iodide 作用下, 以 乙腈 为溶剂, 反应 2.0h, 以82%的产率得到methyl-2,3-didehydro-4,7,8,9-tetra-O-acetyl-N-acetylneuraminate
    参考文献:
    名称:
    Access to 3-O-Functionalized N-Acetylneuraminic Acid Scaffolds
    摘要:
    Direct access to 3-O-functionalized 2-alpha-Nacetylneurarninides and their corresponding 2,3-dehydro-2-deoxy-N-acetylneuraminic acid derivatives is described. Initially, a stereoselective ring-opening of the key intermediate N-acetylneuraminic acid (Neu5Ac) 2,343-epoxide with an alcohol provided the 3-hydroxy alpha-glycoside. O-Allcylation of the C3 hydroxyl group generated novel 3-O-functionalized Neu5Ac derivatives that provided the corresponding unsaturated derivatives upon elimination.
    DOI:
    10.1021/acs.joc.5b00992
  • 作为产物:
    描述:
    methyl-2,3-didehydro-4,7,8,9-tetra-O-acetyl-N-acetylneuraminate 在 sodium bromide 作用下, 以 乙腈 为溶剂, 反应 2.0h, 以98%的产率得到methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-2,3-dibromo-2,3,5-trideoxy-β-D-erythro-L-manno-non-2-ulopyranosonate
    参考文献:
    名称:
    Functionalization of 2-Deoxy-2,3-dehydro-N-acetylneuraminic Acid Methyl Ester
    摘要:
    乙酰基保护的2-脱氧-2,3-脱氢神经氨酸甲酯通过修饰其2,3-双键进行功能化,将其转化为新的糖基供体,例如2,3-二溴-、2,3-环氧-和2-卤代-3-羟基神经氨酸衍生物。
    DOI:
    10.1246/bcsj.60.631
点击查看最新优质反应信息

文献信息

  • [EN] ANTI -INFLUENZA AGENTS<br/>[FR] AGENTS ANTIGRIPPAUX
    申请人:UNIV GRIFFITH
    公开号:WO2011006208A1
    公开(公告)日:2011-01-20
    The present invention relates to compounds that selectively inhibit influenza A virus group (1) sialidases and are therefore potential anti-influenza agents.
    本发明涉及选择性抑制流感A病毒群(1)唾液酸酶的化合物,因此是潜在的抗流感药物。
  • ANTI-INFLUENZA AGENTS
    申请人:Von Itzstein Mark
    公开号:US20120202877A1
    公开(公告)日:2012-08-09
    The present invention relates to compounds that selectively inhibit influenza A virus group (1) sialidases and are therefore potential anti-influenza agents.
    本发明涉及选择性抑制流感A病毒群(1)唾液酸酶的化合物,因此是潜在的抗流感药物。
  • A Stereospecific Synthesis of β-Glycosides of<i>N</i>-Acetylneuraminic Acid and Secondary Alcohols
    作者:Kaoru Okamoto、Tadao Kondo、Toshio Goto
    DOI:10.1246/cl.1986.1449
    日期:1986.9.5
    Glycosylation of secondary alcohols such as cholesterol, methyl 2,4,6-tri-O-benzylgalactopyranoside, and 2-deoxy-2,3-dehydro-NeuAc methyl ester with a new glycosyl donor, 2β,3α-dibromo-2-deoxy-NeuAc methyl ester, selectively gave the corresponding β-glycosides in high yields. The 3α-bromo-glycosides were debrominated with tri-n-butylstannane to the corresponding glycosides, which were deprotected to
    仲醇如胆固醇甲基 2,4,6-tri-O-benzylgalactopyranoside 和 2-deoxy-2,3-dehydro-NeuAc 甲与新的糖基供体 2β,3α-dibromo-2-deoxy 的糖基化-NeuAc 甲,选择性地以高产率得到相应的 β-糖苷。3α--糖苷用三正丁基锡烷为相应的糖苷,将其保护得到具有β-NeuAc的游离糖苷。
  • Synthesis and Biological Evaluation of Several Dephosphonated Analogues of CMP-Neu5Ac as Inhibitors of GM3-Synthase
    作者:Paola Rota、Federica Cirillo、Marco Piccoli、Antonio Gregorio、Guido Tettamanti、Pietro Allevi、Luigi Anastasia
    DOI:10.1002/chem.201501770
    日期:2015.10.5
    hypoxic stress, suggesting that a pharmacological inhibition of the GM3 synthesis could be instrumental for the development of new treatments for ischemic diseases. Herein, the synthesis of several dephosphonated CMP‐Neu5Ac congeners and their anti‐GM3‐synthase activity is reported. Biological activity testes revealed that some inhibitors almost completely blocked the GM3‐synthase activity in vitro and reduced
    先前的研究表明,降低成肌细胞中GM3的含量会增强细胞对缺应激的抵抗力,这表明对GM3合成的药理抑制作用可能有助于开发缺血性疾病的新疗法。在这里,有几个dephosphonated CMP-Neu5Ac的同类物的合成及其抗-报道GM3合酶活性。生物活性睾丸显示,一些抑制剂在体外几乎完全阻断了GM3合酶的活性,并降低了活的胚胎肾脏293A细胞中GM3的含量,最终激活了表皮生长因子受体(EGFR)信号级联。
  • Sim, Mui Mui; Kondo, Hirosato; Wong, Chi-Huey, Journal of the American Chemical Society, 1993, vol. 115, # 6, p. 2260 - 2267
    作者:Sim, Mui Mui、Kondo, Hirosato、Wong, Chi-Huey
    DOI:——
    日期:——
查看更多